CRC
HAE icon

Curi RMB Capital’s Haemonetics HAE Stock Holding History

Curi RMB Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Buy
6,589
+19
+0.3% +$1.22K 0.01% 604
2026
Q1 		$370K Sell
6,570
-366
-5% -$23.8K 0.01% 678
2025
Q4 		$556K Sell
6,936
-1,389
-17% -$93.3K 0.01% 579
2025
Q3 		$406K Hold
8,325
– – 0.01% 545
2025
Q2 		$621K Buy
+8,325
New +$551K 0.01% 478

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Curi RMB Capital's HAE Position: Q2 2026 in Review

Curi RMB Capital increased its Haemonetics (HAE) stake by 0.29% in Q2 2026, buying an estimated $1.22K and bringing the position to 6,589 shares worth $494K. The position accounts for 0.01% of the portfolio, ranked #604.

Curi RMB Capital first reported a position in HAE in Q2 2025 and has held it in 5 quarters since. The position peaked at $621K in Q2 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Curi RMB Capital held 6,589 shares of Haemonetics worth $494K as of Q2 2026.
  • Curi RMB Capital bought 19 Haemonetics shares in Q2 2026, an estimated $1.22K.
  • Haemonetics made up 0.01% of Curi RMB Capital's portfolio in Q2 2026, its #604 holding.
  • Curi RMB Capital first reported a position in Haemonetics in Q2 2025 and has held it in 5 quarters since.
  • Curi RMB Capital's Haemonetics position peaked at $621K in Q2 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Curi RMB Capital's 13F filing for Q2 2026, filed 14 Aug 2026.